Testing for Group B Strep can save lives

A Group B Strep (GBS) screening pilot at Northwick Park hospital resulted in an 80 percent reduction in newborn infection. More than 5,300 mothers at the North West Healthcare NHS trust were tested for GBS over a period of 18 months from 2014 to 2015. If the mothers were GBS positive they were offered Intravenous antibiotics in labour to reduce the risk of GBS transmission.

The results from the pilot were similar to the GBS reduction rates in the countries which routinely screen. The following countries who routinely screen for GBS have seen a fall in infection by 71-86%: Australia, Argentina, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, Czech Republic, Dubai, France, Germany, Hong Kong, Hungary, Iran, Italy, Japan, Lithuania, New Zealand, Norway, Oman, Poland, Portugal, Singapore, Spain, Slovenia, Switzerland, Taiwan, Thailand, Trinidad and Tobago, and the USA.

Routine screening for GBS is not available on the NHS. In the UK 2 babies a day develop GBS infection, 1 baby a week to dies and 1 baby a week survives with long term disability. The Royal College of Obstetricians and Gynaecologists (RCOG) recommend that all women are informed about GBS, however less than 50 percent of pregnant women are still not aware.

Testing for GBS could save a life. Strepelle is a home to laboratory test designed to detect GBS, when the test is performed from 35 weeks gestation it gives a high predictor that a woman will have the same status when she is most likely to go into labour. Do you want to know if you are carrying GBS in your pregnancy? A Strepelle test can be purchased at www.strepelle.com.

To read the article on the Northwick hospital trial: clickhere